These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3509398)

  • 21. Bioavailability in human volunteers of three intramuscular formulations of cefonicid: a long-acting cephalosporin.
    Brumfitt W; James I; Hamilton-Miller JM; Grady D; Price C
    Biopharm Drug Dispos; 1988; 9(3):251-7. PubMed ID: 3395666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of cefonicid with other beta-lactams regarding the effect of human and mouse sera on antibacterial activity.
    Uri JV
    Acta Microbiol Hung; 1987; 34(1):39-44. PubMed ID: 3630630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of age and renal function on cefonicid pharmacokinetics.
    Trang JM; Monson TP; Ackerman BH; Underwood FL; Manning JT; Kearns GL
    Antimicrob Agents Chemother; 1989 Feb; 33(2):142-6. PubMed ID: 2719458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of cefonicid in patients with skin and skin structure infections.
    Heim-Duthoy KL; Peltier GL; Guay DR; Matzke GR
    Antimicrob Agents Chemother; 1988 Apr; 32(4):485-7. PubMed ID: 3377460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Review of cefonicid, a long-acting cephalosporin.
    Dudley MN; Quintiliani R; Nightingale CH
    Clin Pharm; 1984; 3(1):23-32. PubMed ID: 6365414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-over study of the pharmacokinetics of cefonicid administered intravenously or intramuscularly to healthy adult humans.
    Fourtillan JB; Leroy A; Lefebvre MA; Humbert G; Fillastre JP; Reumont G; Ramis N
    Eur J Drug Metab Pharmacokinet; 1985; 10(3):225-30. PubMed ID: 3936717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peritoneal transport of cefonicid.
    Morse GD; Lane T; Nairn DK; Deterding J; Curry J; Gal P
    Antimicrob Agents Chemother; 1987 Feb; 31(2):292-4. PubMed ID: 3566253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical efficacy of cefonicid in the treatment of staphylococcal infections.
    Lentnek AL; Evrard HM; Wikler MA; Sohn CA; Phillips SW
    Clin Ther; 1985; 7(6):725-32. PubMed ID: 4075363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-performance liquid chromatographic determination of cefonicid in human plasma and urine.
    Brendel E; Zschunke M; Meineke I
    J Chromatogr; 1985 May; 339(2):359-65. PubMed ID: 4008574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cefamandole nafate to cefamandole by microbiological assay.
    Winely CL; Spears JC; Scott JK
    Antimicrob Agents Chemother; 1979 Sep; 16(3):424-6. PubMed ID: 41479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penetration of cefonicid into human breast milk and various body fluids and tissues.
    Lou MA; Wu YH; Jacob LS; Pitkin DH
    Rev Infect Dis; 1984; 6 Suppl 4():S816-20. PubMed ID: 6522923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro activity and clinical pharmacology of cefamandole in comparison to cephalothin.
    Simon VC; Malerczyk V; Nixdorf F
    J Antimicrob Chemother; 1978 Jan; 4(1):85-90. PubMed ID: 624694
    [No Abstract]   [Full Text] [Related]  

  • 33. Failure of a once-daily regimen of cefonicid for treatment of endocarditis due to Staphylococcus aureus.
    Chambers HF; Mills J; Drake TA; Sande MA
    Rev Infect Dis; 1984; 6 Suppl 4():S870-4. PubMed ID: 6522927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disposition of cefonicid in orthopedic surgery patients.
    Ackerman BH; Trang JM; Nelson CL; Pearce CE; Manning JT; Harrison BH
    Drug Intell Clin Pharm; 1988 Nov; 22(11):864-8. PubMed ID: 3234250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of saturable serum protein binding on the pharmacokinetics of unbound cefonicid in humans.
    Dudley MN; Shyu WC; Nightingale CH; Quintiliani R
    Antimicrob Agents Chemother; 1986 Oct; 30(4):565-9. PubMed ID: 3789691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple-dose pharmacokinetics of cefonicid in patients with impaired renal function.
    Phelps RT; Conte JE
    Antimicrob Agents Chemother; 1986 May; 29(5):913-7. PubMed ID: 3729349
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kinetics and renal handling of cefonicid.
    Pitkin D; Dubb J; Actor P; Alexander F; Ehrlich S; Familiar R; Stote R
    Clin Pharmacol Ther; 1981 Nov; 30(5):587-93. PubMed ID: 7297018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Update on antibiotic therapy. 30) Cefonicid].
    di Nola F
    Minerva Med; 1985 Apr; 76(16):819-25. PubMed ID: 4000526
    [No Abstract]   [Full Text] [Related]  

  • 39. [Efficacy and tolerance of cefonicid in the treatment of respiratory infections].
    Bolognini G; Biage GI
    Recenti Prog Med; 1987 Jun; 78(6):311-2. PubMed ID: 3659557
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cephamandole--pharmacokinetic, pharmacodynamic and clinical examinations (author's transl)].
    Car V; Schönwald S; Lenardic A; Gmajnicki B; Falisevac J
    Lijec Vjesn; 1979 Jun; 101(6):371-4. PubMed ID: 502719
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.